Cellebrite DI Ltd Financials

Market Capitalization ₪3.64 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	69.09
Forward PE	38.00
Price to Sales TTM	$8.68
Price to Book MRQ	$9.92
Enterprise to Revenue	8.10
Enterprise to EBITDA	48.20

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-46.34%
Operating Margin	11.41%
Return on Assets TTM	6.05%
Return on Equity TTM	-115.35%

Income Statement

Revenue TTM	$419,169,984
Revenue per Share TTM	$1.91
Quarterly Revenue Growth	20.10%
Gross Profit TTM	$352,351,008
EBITDA	$68,862,000
Net Income to Common TTM	$-194,235,008
Diluted EPS TTM	$-0.92
Quarterly Earnings Growth YoY	20.06%

Balance Sheet

Total Cash MRQ	$409,486,016
Total Cash per Share MRQ	$1.73
Total Debt MRQ	$
Total Debt to Equity MRQ	2.92
Current Ratio MRQ	1.82
Book Value per Share MRQ	$1.53

Cash Flow

Operating Cash Flow TTM	$143,008,000
Levered Free Cash Flow TTM	$112,159,376

CLBT Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	234,524,697
Float Shares	106,414,614
Avg 10 Volume	1,541,200
Avg 30 Volume	None
Shares Short	1,192,522
Short Ratio	0.72
Short % of Shares	1.03%
% Held by Insiders	45.54%
% Held by Institutions	47.76%

Stock Price Summary

Beta	1.32
Fifty Two Week Low	$11.47
Fifty Two Week High	$26.30
Fifty Two Week Change	21.91%
Day 50 MA	$17.47
Day 200 MA	$19.19

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date